F13.250 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions

Name of the Condition

• Sedative, Hypnotic, or Anxiolytic Dependence with Sedative, Hypnotic or Anxiolytic-Induced Psychotic Disorder with Delusions (ICD-10 Code: F13.250)

Summary

This condition involves a pattern of sedative, hypnotic, or anxiolytic substance use leading to dependence, accompanied by a substance-induced psychotic disorder characterized by delusions. Dependence is marked by a physical or psychological reliance on these drugs, while the psychotic disorder includes persistent false beliefs (delusions) that arise from substance use or withdrawal.

Causes

The condition typically develops from prolonged or misuse of sedative, hypnotic, or anxiolytic medications, such as benzodiazepines or barbiturates. Dependence may stem from therapeutic use that progresses to misuse, while the psychotic disorder can result from acute intoxication, withdrawal, or chronic use. Delusions often emerge as a direct consequence of substance effects on the central nervous system.

Risk Factors

• A history of substance abuse or dependence.
• Co-occurring mental health disorders, such as anxiety or mood disorders.
• Prolonged or high-dose use of sedative, hypnotic, or anxiolytic drugs.
• Genetic or familial predisposition to addiction or psychosis.
• Environmental factors, such as easy access to these substances.

Symptoms

• Strong cravings or compulsive need to use the substance.
• Increased tolerance, requiring higher doses for the same effect.
• Withdrawal symptoms (e.g., anxiety, tremors, insomnia) when not using.
• Persistent delusions (false beliefs) unrelated to cultural or situational context.
• Impaired judgment or behavior due to psychotic symptoms.
• Continued use despite physical, psychological, or social harm.

Diagnosis

Diagnosis requires a clinical evaluation, including patient history, symptom assessment, and ruling out other causes of psychosis (e.g., primary mental disorders). Standardized criteria (e.g., DSM-5) are used to confirm dependence and substance-induced psychotic disorder with delusions. Laboratory tests may assess substance levels, and collateral information from caregivers or records may be helpful.

Treatment Options

Treatment focuses on managing dependence and psychotic symptoms. Options include:

• Medically supervised detoxification to address withdrawal.
• Antipsychotic medications to target delusions, if needed.
• Behavioral therapies (e.g., cognitive-behavioral therapy) to address substance use and psychotic symptoms.
• Support groups or counseling to promote recovery.
• Addressing underlying mental health conditions that may contribute to use.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, adherence to treatment, and co-occurring conditions. With appropriate care, symptoms may improve, but relapse risk remains. Regular follow-up is essential to monitor for recurrence of dependence or psychotic symptoms, adjust treatment, and support long-term recovery.

Complications

• Worsening of psychotic symptoms or development of other substance-induced disorders.
• Physical health issues from prolonged substance use (e.g., liver damage, respiratory depression).
• Social or occupational impairment due to delusions or impaired functioning.
• Increased risk of accidents or self-harm.
• Potential for legal or financial problems related to substance use.

Lifestyle & Prevention

• Avoid non-prescribed use of sedative, hypnotic, or anxiolytic drugs.
• Follow prescribed dosing and duration strictly.
• Seek help for underlying mental health concerns to reduce self-medication.
• Build a support network of family, friends, or support groups.
• Engage in stress-reduction techniques (e.g., exercise, mindfulness) to manage anxiety without substance use.

When to Seek Professional Help

Seek immediate care if experiencing:

• Severe delusions or hallucinations that disrupt daily life.
• Withdrawal symptoms (e.g., seizures, extreme agitation).
• Thoughts of self-harm or harm to others.
• Inability to stop using the substance despite negative consequences.
• Deterioration in physical or mental health.

Tips for Medical Coders

Document the presence of both dependence and a sedative, hypnotic, or anxiolytic-induced psychotic disorder with delusions to support code F13.250. Include details on the substance type, duration of use, and clinical evidence of delusions (e.g., patient report, behavioral observations). Ensure documentation aligns with diagnostic criteria for both dependence and the psychotic disorder to justify the code.